<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01575678</url>
  </required_header>
  <id_info>
    <org_study_id>EnuMel-11</org_study_id>
    <secondary_id>2011-004138-33</secondary_id>
    <nct_id>NCT01575678</nct_id>
  </id_info>
  <brief_title>The Effect of Melatonin on Nocturnal Enuresis</brief_title>
  <official_title>The Effect of Melatonin on Nocturnal Enuresis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim: To investigate the effect of melatonin in bedwetting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: Double blind randomized placebocontrolled trial using crossover.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of incontinence episodes</measure>
    <time_frame>10 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>nocturnal blood pressure</measure>
    <time_frame>4 weeks</time_frame>
    <description>Time frame:
Week 1: Baseline. Week 5: Effect of 1st treatment arm. Week 6: Wash out. Week 10: Effect of 2nd treatment arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>activity level</measure>
    <time_frame>4 weeks</time_frame>
    <description>Time frame:
Week 1: Baseline. Week 5: Effect of 1st treatment arm. Week 6: Wash out. Week 10: Effect of 2nd treatment arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bladder capacity</measure>
    <time_frame>4 weeks</time_frame>
    <description>Time frame:
Week 1: Baseline. Week 5: Effect of 1st treatment arm. Week 6: Wash out. Week 10: Effect of 2nd treatment arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nocturnal urine production</measure>
    <time_frame>4 weeks</time_frame>
    <description>Time frame:
Week 1: Baseline. Week 5: Effect of 1st treatment arm. Week 6: Wash out. Week 10: Effect of 2nd treatment arm.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Nocturnal Enuresis</condition>
  <arm_group>
    <arm_group_label>Melatonin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactose</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <description>blinded capsule 2-4 mg/day, oral use, for 4 weeks</description>
    <arm_group_label>Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactose</intervention_name>
    <description>blinded capsule 1/day, oral use, for 4 weeks</description>
    <arm_group_label>Lactose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Monosymptomatic nocturnal enuresis

          -  Age 6-14 years

          -  Clinical examination normal

          -  ≥ 3 wet nights / week due to either nocturnal polyuria with normal bladder size or
             reduced functional bladder capacity with normal urine output

        Exclusion Criteria:

          -  Constipation (by ROME III criteria)

          -  Day incontinence

          -  Overactive bladder (ICCS 2008 classification of symptoms)

          -  Current or past history of clinical or laboratory findings that can be related to
             diseases or - conditions (eg pregnancy) likely to change the parameters examined,
             especially diseases of the kidney and urinary tract, liver or endocrine disorder.

          -  Clinical signs of urinary tract infection

          -  Hypertension, blood pressure assessed by ambulatory measurement with blood pressure
             cuff

          -  Set treatment with one or more drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Søren Rittig, MD, dr.med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pediatric department, Aarhus Universityhospital, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Søren Rittig, MD, dr.med, professor</last_name>
    <email>rittig@ki.au.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Britt Borg, MS</last_name>
    <phone>+4578451523</phone>
    <email>bborg@ki.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center of Child Incontinence, Pediatric department, Aarhus Universityhospital</name>
      <address>
        <city>Aarhus</city>
        <state>Region Midtjylland</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Britt Borg, postgrad. medical student</last_name>
      <phone>+45 78451523</phone>
      <email>bborg@ki.au.dk</email>
    </contact>
    <investigator>
      <last_name>Kostas Kamperis, MD, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Birgitte Mahler, MD, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Britt Borg, postgrad. medical student</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2012</study_first_submitted>
  <study_first_submitted_qc>April 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2012</study_first_posted>
  <last_update_submitted>November 1, 2012</last_update_submitted>
  <last_update_submitted_qc>November 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>enuresis</keyword>
  <keyword>melatonin</keyword>
  <keyword>circadian rhythm</keyword>
  <keyword>children</keyword>
  <keyword>blood pressure</keyword>
  <keyword>urine production</keyword>
  <keyword>activity</keyword>
  <keyword>sleep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Nocturnal Enuresis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

